1. LncRNA SBF2 Antisense RNA 1 Accelerates the Progression of Colon Cancer via PI3K/Akt/mTOR Signaling Pathway by Targeting miR-506-3p/ZEB1 Axis
   Fei Yang et al, 2023, Journal of Biomedical Nanotechnology CrossRef
2. MicroRNA-506 is up-regulated in the development of pancreatic ductal adenocarcinoma and is associated with attenuated disease progression
   Run-Fen Cheng et al, 2016, Chinese Journal of Cancer CrossRef
3. The Role of PIM Kinases in Pediatric Solid Tumors
   Janet Rae Julson et al, 2022, Cancers CrossRef
4. Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application
   V. Taucher et al, 2016, Cellular Oncology CrossRef
5. The emerging role of miR-506 in cancer
   Jian Li et al, 2016, Oncotarget CrossRef
6. The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma
   Zhuqing Gao et al, 2019, Analytical Cellular Pathology CrossRef
7. Metastatic pancreatic cancer: Mechanisms and detection (Review)
   Xiangling Chen et al, 2021, Oncology Reports CrossRef
8. Therapeutic miR-506-3p Replacement in Pancreatic Carcinoma Leads to Multiple Effects including Autophagy, Apoptosis, Senescence, and Mitochondrial Alterations In Vitro and In Vivo
   Hannes Borchardt et al, 2022, Biomedicines CrossRef
9. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis
   Wenchong Song et al, 2021, American Journal of Physiology-Gastrointestinal and Liver Physiology CrossRef
10. Development of microRNA-based therapy for pancreatic cancer
    Andrew Fesler et al, 2019, Journal of Pancreatology CrossRef
11. MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype
    Tiantian Yang et al, 2023, Biomedicines CrossRef
12. MiR-506 suppresses cell proliferation and tumor growth by targeting Rho-associated protein kinase 1 in hepatocellular carcinoma
    Quanjun Deng et al, 2015, Biochemical and Biophysical Research Communications CrossRef
13. MiR‑506 inhibits cell proliferation, invasion, migration and epithelial‑to‑mesenchymal transition through targeting RWDD4 in human bladder cancer
    Yi Hou, 2018, Oncology Letters CrossRef
14. MIR506induces autophagy-related cell death in pancreatic cancer cells by targeting the STAT3 pathway
    Longhao Sun et al, 2017, Autophagy CrossRef
15. Association between aberrant dynein cytoplasmic�1 light intermediate chain�1 expression levels, mucins and chemosensitivity in colorectal cancer
    Chun‑Chao Chang et al, 2020, Molecular Medicine Reports CrossRef
16. Targeting Pim kinases in hematological cancers: molecular and clinical review
    Marcia Bellon et al, 2023, Molecular Cancer CrossRef
17. microRNA based prognostic biomarkers in pancreatic Cancer
    Shixiang Guo et al, 2018, Biomarker Research CrossRef
18. PIM3 regulates myocardial ischemia/reperfusion injury via ferroptosis
    Ting Li et al, 2024, Genes & Genomics CrossRef